Webster Equity Partners, L.P.

Webster Equity Partners serves as investment adviser to 25 private equity funds and manages about $10.3 billion on a discretionary basis, providing advisory and management services tailored to each fund’s governing documents. Its funds invest primarily in healthcare services companies in the U.S. and Canada; as of December 31, 2025 the funds had invested in 52 companies and were actively monitoring 27 portfolio companies.

The firm shifted its strategy in 2020 to concentrate exclusively on healthcare services, targeting mission‑critical, patient‑centric businesses in fragmented sub‑sectors and generally pursuing majority‑control or structured paths to control. Webster Equity targets middle‑market companies with revenues of $20–$200 million, typically deploying $25–$100 million of equity per transaction with moderate leverage, and applies a diligence framework that incorporates sustainability analysis (including SASB guidance) and investment‑committee review.

Webster Equity’s brochure discloses a few practices that distinguish it from many peers: it engages third‑party promoters and discloses the use of endorsements in fundraising and marketing, and it has documented third‑party financing arrangements used to fund principals’ GP commitments. The firm also describes formal conflict‑mitigation mechanisms (advisory boards, IC approval processes, standardized disclosure templates) and a written Responsible Investment and Stewardship Policy integrated across the investment lifecycle.